TELA Bio (NASDAQ: TELA) COO/CFO reports stock grants and RSU tax withholdings
Rhea-AI Filing Summary
TELA Bio, Inc. executive Roberto Cuca, the COO and CFO, reported a mix of equity awards and tax-related share withholdings. On February 20, 2026, he received a grant of 85,000 stock options and an award of 57,000 shares of common stock, both as direct ownership. The options vest over four years starting February 20, 2027, and the share award consists of RSUs vesting in four equal annual installments beginning the same date, subject to continued service.
To cover withholding taxes on RSU vesting, the issuer withheld 4,780 shares on February 21, 2026 at $0.7174 per share and 5,234 shares on February 23, 2026 at $0.7660 per share, characterized as tax-withholding dispositions rather than open-market sales. After these transactions, Cuca directly owned 257,377 shares of common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Common Stock | 5,234 | $0.766 | $4K |
| Tax Withholding | Common Stock | 4,780 | $0.7174 | $3K |
| Grant/Award | Stock Option (Right to Buy) | 85,000 | $0.00 | -- |
| Grant/Award | Common Stock | 57,000 | $0.00 | -- |
Footnotes (1)
- These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 20, 2027, subject to the Reporting Person's continuous service through the applicable vesting dates. Includes 1,079 shares acquired under the Company's employee stock purchase plan on each of July 31, 2025 and January 30, 2026. Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs. The option vests 25% on February 20, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.